4
Changes in Ownership
Edwards Lifesciences Corp Filed Acc 0001225208-24-010647
CVP, Chief Financial Officer sold 11,250 shares at $71.68 ($806,406)
- CVP, Chief Financial Officer acquired 11,250 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Ullem Scott B. · CVP, Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-12-09 | Exercise or conversion : show line 1 in the form 10b5-1 | +11,250 | $45.28 | $509,363 | 41,811 | D |
| 2024-12-09 | Sale : show line 2 in the form 10b5-1 | −11,250 | $71.68 | $806,406 | 30,561 | D |
| Open-market sales · 11,250 sh · avg $71.68 · $806,406 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-12-09 | Exercise or conversion : show line 3 in the form 10b5-1 Employee Stock Option (Right to Acquire) | −11,250 | 45,000 | D |
Loading xslF345X05/doc4.xml…